Download The Case Study
Successful approaches from recent cell therapy trial
Successful approaches from recent cell therapy trial
Operational Strategies for Success in Cell Therapy Clinical Development
In a newly-released case study, Medpace cell and gene therapy experts evaluate a study of intraperitoneally administered allogenic cell therapy in patients with adenocarcinoma.
Download the new case study to explore successful approaches from the recent cellular and gene therapy clinical success:
Cell and Gene Therapy
An integrated Approach
Medpace has contributed to over 130 CGT (cell and gene therapy) trials, including advancement through marketing authorization approval. This depth of experience highlights our ability to manage the most complex and innovative advanced therapy trials. Gain the Medpace advantage:
- Dedicated CGT experts for clinical trial delivery—across numerous therapeutic areas and global regions including Asia Pacific, Europe, and the US—demonstrated by 130+ cell and gene therapy trials
- Comprehensive regulatory affairs and operational experts who work collaboratively with our medical team
- Integrated laboratory services, providing an array of CGT lab capabilities for cohesive, streamlined, and standardized trial management
